Intellectus Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbCellera Biologics
ABCL
|
+$33.3M |
| 2 |
Lam Research
LRCX
|
+$3.84M |
| 3 |
SRTA
Strata Critical Medical Inc
SRTA
|
+$1.67M |
| 4 |
iShares Silver Trust
SLV
|
+$1.54M |
| 5 |
AFMD
Affimed
AFMD
|
+$1.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intellia Therapeutics
NTLA
|
+$1.79M |
| 2 |
Virgin Galactic
SPCE
|
+$1.1M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$947K |
| 4 |
Blackstone
BX
|
+$874K |
| 5 |
IACA
ION Acquisition Corp 1 Ltd.
IACA
|
+$819K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 19.51% |
| 2 | Healthcare | 19.33% |
| 3 | Technology | 19.31% |
| 4 | Consumer Discretionary | 12.84% |
| 5 | Communication Services | 8.56% |
Similar funds
Intellectus Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Intellectus Partners held 280 positions worth $443M, up 22% from $364M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Intellectus Partners deployed $58.1M of net new capital in Q2 2021, opening 38 new positions and adding to 121 existing holdings. Its largest new stake was AbCellera Biologics: 1,206,979 shares worth $26.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Intellia Therapeutics, an estimated $1.79M trimmed.
- Intellectus Partners's largest Q2 2021 buy was AbCellera Biologics: 1,206,979 shares worth $26.6M.
- Intellectus Partners added most to iShares Silver Trust in Q2 2021, an estimated $1.54M increase.
- Intellectus Partners's biggest Q2 2021 reduction was Intellia Therapeutics, cutting an estimated $1.79M.
- Intellectus Partners fully exited Virgin Galactic in Q2 2021, selling an estimated $1.1M.
- Intellectus Partners's ten largest holdings make up 29% of its $443M portfolio in Q2 2021.
- Intellectus Partners opened 38 new positions and closed 8 in Q2 2021.
- Intellectus Partners's portfolio value rose 22% quarter-over-quarter to $443M.
Based on Intellectus Partners's 13F filing for Q2 2021, filed 13 Aug 2021.